These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 799966

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. In situ identification of activated Ta1+ T lymphocytes in human leprosy skin lesions.
    Shen JY, Hofman FM, Gunter JR, Modlin RL, Rea TH.
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):494-8. PubMed ID: 2443587
    [Abstract] [Full Text] [Related]

  • 3. Immune responses to mycobacterium leprae in man.
    Myrvang B.
    J Oslo City Hosp; 1975 Jan; 25(1):3-24. PubMed ID: 1092818
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Enhanced cell-mediated immune responses in erythema nodosum leprosum reactions of leprosy.
    Rao TD, Rao PR.
    Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):36-41. PubMed ID: 3549939
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Changes in circulating antibody levels to the major phenolic glycolipid during erythema nodosum leprosum in leprosy patients.
    Andreoli A, Brett SJ, Draper P, Payne SN, Rook GA.
    Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):211-7. PubMed ID: 3894538
    [Abstract] [Full Text] [Related]

  • 8. Immunological aspects of leprosy: ten years' activity at the Armauer Hansen Research Institute and Prospects for further work.
    Harboe M.
    Int J Lepr Other Mycobact Dis; 1980 Jun; 48(2):193-205. PubMed ID: 6156919
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR, Chiplunkar SV, Butlin R, Samson PD, Deo MG, Gangal SG.
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Concanavalin A induced suppressor activity in human leprosy.
    Nath I, Narayanan RB, Mehra NK, Sharma AK, Gupte MD.
    J Clin Lab Immunol; 1979 Nov; 2(4):319-24. PubMed ID: 161322
    [Abstract] [Full Text] [Related]

  • 20. Presence of soluble, Mycobacterium leprae-derived antigen in the inflammatory exudate of reactional lepromatous leprosy.
    Rojas-Espinosa O, González-Mendoza A, Estrada-Parra S, Ortíz Y, González-Cruz O, Cornejo AL, Pérez-Suarez G.
    Lepr Rev; 1985 Sep; 56(3):229-38. PubMed ID: 3903409
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.